Clinical Trials · NCT03792555
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Enrollment
- 13
- Start date
- Mar 2019
- Locations
- 11 sites, 8 countries
- Primary endpoint
- Responder Criteria Was Based on the Mean of Two Consecutive Insulin-like Growth Factor-1 [IGF-1] Measurements ≤ULN at Week 13